DiscGenics
Categories
Pharmaceuticals/Therapeutics
About
DiscGenics is a biotechnology company developing advanced spinal stem cell therapeutics to treat patients with diseases of the intervertebral disc.
Membership Type
Industry Member
Contacts
Mr. Anthony Mangum MBA
Senior Analyst: Finance & Operations
Nicole Bowen
Manager, QC and Analytical Development
Scott Butters
Controller
Dr. Isaac Erickson PhD
Development Engineer
Flagg Flanagan
President/CEO
Nancy Rose
HR Director
Lindsey Saxon
Branding
Dr. Lara Silverman PhD
Manager R&D
Jamie Strate
Bob Wynalek
Chief Operating & Commercialization Officer
